v3.26.1
Balance Sheet Details - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts payable $ 13,248 $ 22,611
Accrued clinical trial costs 10,213 7,369
Accrued outside services and professional fees 6,191 4,430
Accrued research and development costs 5,628 4,506
Accrued transaction-related costs 2,281 0
Other accrued expenses 4,878 2,854
Total $ 42,439 $ 41,770